|Home||» Products||» Gefitinib Tablets||» Geftinat Meds|
Geftinat (Iressa or Gefitinib) is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib. Geftinat (Iressa or Gefitinib) may also be used for purposes other than those listed in this drug information guide.
Note: Geftinat is a prescription drug and should be used under proper medical guidance and advice.
- Contact Details
- MODERN TIMES HELP LINES PHARMA